Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Blankenstein

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
Anticancer Research|April 30, 2016
Expression of Activin During and After Chemotherapy in Peripheral Blood of Patients with Primary Breast CancerJulia Jueckstock, Natalie Burkhardt, Christina Kuhn, et al.
Immunity|August 17, 2004
CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditionsLars Ohl, Mariette Mohaupt, Niklas Czeloth, et al.
Leukemia|January 5, 2019
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapiesNeşe Çakmak-Görür, Josefine Radke, Simone Rhein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2010
In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL toleranceChristian Buschow, Jehad Charo, Kathleen Anders, et al.
Haematologica|September 28, 2023
HLA-C*04:09N is expressed at the cell surface and triggers peptide-specific T-cell activationCarlotta Welters, Marthe-Lina Welters, Serena Stadler, et al.
Frontiers in Immunology|February 23, 2019
Interferon-γ Receptor Signaling in Dendritic Cells Restrains Spontaneous Proliferation of CD4<sup>+</sup> T Cells in Chronic Lymphopenic MiceLaura Knop, Charlotte Frommer, Diana Stoycheva, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2008
Engineering antigen-specific primary human NK cells against HER-2 positive carcinomasAnna Kruschinski, Andreas Moosmann, Isabel Poschke, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Fas expression by tumor stroma is required for cancer eradicationJoanna J Listopad, Thomas Kammertoens, Kathleen Anders, et al.
Cancer Cell|December 17, 2011
Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancerKathleen Anders, Christian Buschow, Andreas Herrmann, et al.
International Journal of Cancer|January 30, 2004
CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cellsJan Alvar Lindencrona, Susanne Preiss, Thomas Kammertoens, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Anticancer Research|April 30, 2016
Expression of Activin During and After Chemotherapy in Peripheral Blood of Patients with Primary Breast CancerJulia Jueckstock, Natalie Burkhardt, Christina Kuhn, et al.
Immunity|August 17, 2004
CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditionsLars Ohl, Mariette Mohaupt, Niklas Czeloth, et al.
Leukemia|January 5, 2019
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapiesNeşe Çakmak-Görür, Josefine Radke, Simone Rhein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2010
In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL toleranceChristian Buschow, Jehad Charo, Kathleen Anders, et al.
Haematologica|September 28, 2023
HLA-C*04:09N is expressed at the cell surface and triggers peptide-specific T-cell activationCarlotta Welters, Marthe-Lina Welters, Serena Stadler, et al.
Frontiers in Immunology|February 23, 2019
Interferon-γ Receptor Signaling in Dendritic Cells Restrains Spontaneous Proliferation of CD4<sup>+</sup> T Cells in Chronic Lymphopenic MiceLaura Knop, Charlotte Frommer, Diana Stoycheva, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2008
Engineering antigen-specific primary human NK cells against HER-2 positive carcinomasAnna Kruschinski, Andreas Moosmann, Isabel Poschke, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Fas expression by tumor stroma is required for cancer eradicationJoanna J Listopad, Thomas Kammertoens, Kathleen Anders, et al.
Cancer Cell|December 17, 2011
Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancerKathleen Anders, Christian Buschow, Andreas Herrmann, et al.
International Journal of Cancer|January 30, 2004
CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cellsJan Alvar Lindencrona, Susanne Preiss, Thomas Kammertoens, et al.
Pageof 14